Cargando…

Corrigendum: Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice

Detalles Bibliográficos
Autores principales:	Chen, Wei, Shui, Fengchun, Liu, Cheng, Zhou, Xinbo, Li, Wei, Zheng, Zhibing, Fu, Wei, Wang, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712340/ https://www.ncbi.nlm.nih.gov/pubmed/29206243 http://dx.doi.org/10.3389/fphar.2017.00890

Ejemplares similares

Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice
por: Chen, Wei, et al.
Publicado: (2017)

Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2021)

AM-251, A Cannabinoid Antagonist, Modifies the Dynamics of Sleep–Wake Cycles in Rats
por: Bogáthy, Emese, et al.
Publicado: (2019)

The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice
por: Micale, Vincenzo, et al.
Publicado: (2019)

Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists
por: Butler, Helen, et al.
Publicado: (2009)

Prominent Effects of Berbamine Hydrochloride on Alzheimer’s Disease Model Mice
por: Chen, Chang-lan, et al.
Publicado: (2022)

Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1
por: Ratano, Patrizia, et al.
Publicado: (2017)

Peripherally Administered Y(2)-Receptor Antagonist BIIE0246 Prevents Diet-Induced Obesity in Mice With Excess Neuropeptide Y, but Enhances Obesity in Control Mice
por: Ailanen, Liisa, et al.
Publicado: (2018)

Should oncologists trust cannabinoids?
por: Creanga-Murariu, Ioana, et al.
Publicado: (2023)

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
por: Turcotte, Caroline, et al.
Publicado: (2016)

Emerging Role of (Endo)Cannabinoids in Migraine
por: Leimuranta, Pinja, et al.
Publicado: (2018)

Antitumor Cannabinoid Chemotypes: Structural Insights
por: Morales, Paula, et al.
Publicado: (2019)

Can Prescribed Cannabinoids Substitute Cannabis?
por: Batalla, A.
Publicado: (2022)

Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules
por: Zagzoog, Ayat, et al.
Publicado: (2022)

Voltage dependence of the cannabinoid CB1 receptor
por: Goldberger, Esty, et al.
Publicado: (2022)

Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator
por: Xie, Xinni, et al.
Publicado: (2017)

Cannabis, cannabinoids, and health
por: Lafaye, Genevieve, et al.
Publicado: (2017)

Syzygium cumini (L.) skeels: a prominent source of bioactive molecules against cardiometabolic diseases
por: Chagas, Vinicyus Teles, et al.
Publicado: (2015)

Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
por: Yeoh, Jiann Wei, et al.
Publicado: (2014)

Targeting the endogenous cannabinoid system to treat neuropathic pain
por: Lau, Benjamin K., et al.
Publicado: (2014)

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2016)

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
por: Aso, Ester, et al.
Publicado: (2014)

Cannabinoids and Pain: New Insights From Old Molecules
por: Vučković, Sonja, et al.
Publicado: (2018)

Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting
por: Rock, Erin M., et al.
Publicado: (2016)

New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling
por: Riquelme-Sandoval, Agustín, et al.
Publicado: (2020)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
por: Smoum, Reem, et al.
Publicado: (2022)

Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
por: Grohs, Laura, et al.
Publicado: (2023)

Long-term consequences of adolescent cannabinoid exposure in adult psychopathology
por: Renard, Justine, et al.
Publicado: (2014)

Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat
por: Vera, Gema, et al.
Publicado: (2017)

Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research
por: Ruggiero, Rafael N., et al.
Publicado: (2017)

Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives
por: Götz, Marcus R., et al.
Publicado: (2019)

Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
por: Walsh, Kenneth B., et al.
Publicado: (2021)

Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection
por: Vicente-Acosta, Andrés, et al.
Publicado: (2022)

Potential effects of cannabinoids on audiovestibular function: A narrative review
por: Guerra, Joaquin, et al.
Publicado: (2022)

Interactions of Echinacea spp. Root Extracts and Alkylamides With the Endocannabinoid System and Peripheral Inflammatory Pain
por: Liu, Rui, et al.
Publicado: (2021)

Melatonin Mediates Osteoblast Proliferation Through the STIM1/ORAI1 Pathway
por: Cao, Lili, et al.
Publicado: (2022)

On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity
por: Wiskerke, Joost, et al.
Publicado: (2012)

Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
por: Befort, Katia
Publicado: (2015)

Corrigendum: Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages
por: Chuang, Yen-Chieh, et al.
Publicado: (2023)

Crocin-I Protects Against High-Fat Diet-Induced Obesity via Modulation of Gut Microbiota and Intestinal Inflammation in Mice
por: Xie, Xiaoxian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ssdgso0temvhnvo0nmqv2ovdc2